Skip to main content
UniHealth

Doctor search

Jennifer Christy Alyono, MD

Otolaryngology · Stanford

NPI 1790075026

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
5
2 carriers
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

5 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alyono’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

5 of 5 plans

Plans whose provider directory lists this clinician
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A123854 · Current

Licensed to practise in California · since 2012 · expires 2028-10-31 · University of California, San Diego School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$75,760

Medicare paid this office $75,760 for 276 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Insertion of cochlear device15$17,184$1,146
Short return visit (20+ min)132$10,812$56
Return visit (30+ min)85$8,691$87
New patient visit (45+ min)68$6,975$103
New patient visit (30+ min)36$2,473$69

Who their Medicare patients are

276 Original Medicare patients in 2024. Average age 73 · Under 65 9% · 85 and older 12% · Women 53% · Also on Medicaid 24% · Health risk score 1.43. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.

Conditions among them: High blood pressure 67% · Coronary heart disease 26% · Diabetes 25% · Chronic kidney disease 22% · Cancer 16% · Depression 16% · Atrial fibrillation 14% · Heart failure 13% · COPD 11% · Stroke 11% · Dementia 5%.

The office billed $502,696, Medicare allowed $99,125 and paid $75,760; for 492 services of 42 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024276492731.43$502,696$75,760
2023255444741.22$361,372$66,420
2022249431741.28$336,311$60,315
2021243564731.30$358,190$70,410
2020228519731.40$264,986$46,666
2019227461721.48$301,330$51,326
201866101711.27$79,965$11,679

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Original Medicare services billed in 2023
Short return visit (20+ min)123$9,235$52
Return visit (30+ min)74$7,140$83
New patient visit (45+ min)56$6,297$112
New patient visit (30+ min)38$2,424$64

2022: 5 services

Original Medicare services billed in 2022
Return visit (30+ min)94$9,275$83
New patient visit (45+ min)78$8,279$106
Short return visit (20+ min)88$6,918$52
New patient visit (30+ min)19$1,365$72
Short return visit14$375$25

2021: 6 services

Original Medicare services billed in 2021
Return visit (30+ min)133$14,744$83
New patient visit (45+ min)61$6,571$108
Short return visit (20+ min)73$6,524$55
Long return visit (40+ min)14$1,766$126
Exam of ear using a microscope44$598$8
Removal of impacted ear wax16$289$15

2020: 5 services

Original Medicare services billed in 2020
Short return visit (20+ min)107$8,356$42
New patient visit (30+ min)81$5,171$64
Return visit (30+ min)61$3,943$65
Exam of ear using a microscope54$757$8
Removal of impacted ear wax20$744$29

2019: 5 services

Original Medicare services billed in 2019
Short return visit (20+ min)94$6,683$44
New patient visit (30+ min)109$6,644$61
Return visit (30+ min)48$2,989$62
Exam of ear using a microscope40$503$8
Removal of impacted ear wax12$382$27

2018: 2 services

Original Medicare services billed in 2018
New patient visit (30+ min)35$2,320$66
Short return visit (20+ min)21$1,111$44

Medicaid work

$2,924 in 2024

Medicaid paid $2,924 for 64 billed services this clinician did in 2024, up to 19 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Short return visit (20+ min)64$2,924
Medicaid work by year
202464119$2,924
2023113217$2,687
202295218$2,469
202142215$1,236
202085117$1,708
201950117$1,352
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Short return visit (20+ min)89$2,051
Return visit (30+ min)24$636

2022

Largest Medicaid services in 2022
Return visit (30+ min)47$1,437
Short return visit (20+ min)48$1,032

2021

Largest Medicaid services in 2021
Short return visit (20+ min)29$779
Return visit (30+ min)13$456

2020

Largest Medicaid services in 2020
Short return visit (20+ min)85$1,708

2019

Largest Medicaid services in 2019
Short return visit (20+ min)50$1,352

Drugs they prescribed that Part D paid

$6,938

Pharmacies billed $6,938 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 17% of their Part D prescriptions (22 of 128) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.

117 generic and fewer than 11 brand-name prescriptions · $6,938 in drug cost · 40 antibiotic prescriptions to 26 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ciprofloxacin-Dexamethasone16$2,428$116
Ofloxacin13$660$44
Cephalexin22$72$3
Hydrocodone-Acetaminophen21$42$2

Year by year

Part D prescribing by year
20241285817% (22)None$6,938
2023834419% (16)14%$5,070
20228143NoneNone$3,345
20211094512% (13)None$4,167
202011242NoneNone$3,234
20191636513% (21)None$6,358
20183015NoneNone$1,290
2017171271% (12)0%$114
2016262389% (23)None$402
2015382961% (23)None$634
2014171677% (13)0%$170

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 3 drugs

Part D drugs prescribed in 2023
Ciprofloxacin-Dexamethasone15$2,458$164
Cephalexin18$121$7
Hydrocodone-Acetaminophen15$50$3

2022: 1 drug

Part D drugs prescribed in 2022
Ofloxacin22$957$44

2021: 3 drugs

Part D drugs prescribed in 2021
Ofloxacin39$1,756$45
Cephalexin15$76$5
Hydrocodone-Acetaminophen13$60$5

2020: 1 drug

Part D drugs prescribed in 2020
Ofloxacin43$1,480$34

2019: 3 drugs

Part D drugs prescribed in 2019
Ofloxacin63$3,814$61
Cephalexin24$147$6
Hydrocodone-Acetaminophen18$99$5

2017: 1 drug

Part D drugs prescribed in 2017
Hydrocodone-Acetaminophen12$84$7

2016: 1 drug

Part D drugs prescribed in 2016
Hydrocodone-Acetaminophen20$231$12

2015: 1 drug

Part D drugs prescribed in 2015
Hydrocodone-Acetaminophen16$288$18

Money from drug and device companies

$412 in 2025

Industry payments by year
2025212None$412
202411None$145
202312None$122
2022111None$1,700
202111None$89
201911None$71

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Cochlear AmericasCochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode$220
2 payments
  • Meals for Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode · 2025-08-06 · $144
  • Meals for Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode · 2025-03-05 · $76
MedtronicMidas Rex$192
10 payments
  • Meals for Midas Rex · 2025-04-06 · $11
  • Meals for Midas Rex · 2025-04-06 · $2
  • Meals for Midas Rex · 2025-04-06 · $42
  • Meals for Midas Rex · 2025-04-06 · $45
  • Meals for Midas Rex · 2025-04-06 · $2
  • Meals for Midas Rex · 2025-04-05 · $12
  • Meals for Midas Rex · 2025-04-05 · $30
  • Meals for Midas Rex · 2025-04-05 · $2
  • Meals for Midas Rex · 2025-04-05 · $35
  • Meals for Midas Rex · 2025-04-05 · $10
See all 12 published payments
Every published payment
Cochlear AmericasMeals · 2025-08-06Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode$144
MedtronicMeals · 2025-04-06Midas Rex$11
MedtronicMeals · 2025-04-06Midas Rex$2
MedtronicMeals · 2025-04-06Midas Rex$42
MedtronicMeals · 2025-04-06Midas Rex$45
MedtronicMeals · 2025-04-06Midas Rex$2
MedtronicMeals · 2025-04-05Midas Rex$12
MedtronicMeals · 2025-04-05Midas Rex$30
MedtronicMeals · 2025-04-05Midas Rex$2
MedtronicMeals · 2025-04-05Midas Rex$35
MedtronicMeals · 2025-04-05Midas Rex$10
Cochlear AmericasMeals · 2025-03-05Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode$76
See earlier years (2024, 2023, 2022, 2021, 2019)

2024: $145

Payments by company in 2024
DePuy Synthes SalesMatrixorthognathic$145
1 payment
  • Meals for Matrixorthognathic · 2024-09-26 · $145

2023: $122

Payments by company in 2023
Cochlear AmericasCochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode$122
2 payments
  • Meals for Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode · 2023-05-24 · $74
  • Meals for Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode · 2023-02-22 · $48

2022: $1,700

Payments by company in 2022
StrykerN/A$1,700
11 payments
  • Meals for N/A · 2022-06-17 · $28
  • Meals for N/A · 2022-06-17 · $28
  • Meals for N/A · 2022-06-17 · $28
  • Meals for N/A · 2022-05-27 · $109
  • Travel for Core · 2022-05-16 · $20
  • Travel for Core · 2022-05-14 · $26
  • Travel for N/A · 2022-05-14 · $403
  • Meals for N/A · 2022-05-14 · $140
  • Meals for N/A · 2022-05-14 · $40
  • Travel for N/A · 2022-05-13 · $403
  • Travel for Core · 2022-03-24 · $475

2021: $89

Payments by company in 2021
Cochlear AmericasCochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode$89
1 payment
  • Meals for Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode · 2021-12-07 · $89

2019: $71

Payments by company in 2019
Smith+NephewStravix$71
1 payment
  • Meals for Stravix · 2019-06-25 · $71

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Cochlear Americas · A Post-Approval, Prospective, Nonrandomized, Single-Arm Multicenter Investigation To Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-Sided Deafness · 2024Their institution$94,958
Cochlear Americas · A Post-Approval, Prospective, Nonrandomized, Single-Arm Multicenter Investigation To Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-Sided Deafness · 2023Their institution$62,963
Cochlear Americas · A Post-Approval, Prospective, Nonrandomized, Single-Arm Multicenter Investigation To Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-Sided Deafness · 2022Their institution$21,536
Cochlear Americas · A Post-Approval, Prospective, Nonrandomized, Single-Arm Multicenter Investigation To Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-Sided Deafness · 2025Their institution$12,660

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1790075026
Licence
CA A123854California A123854: Current · expires 2028-10-31
Trained
University of California, San Diego School of Medicine, 2011
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207YX0901X (207YX0901X); Otolaryngology (207Y00000X)
Mailing address
801 Welch Rd, Palo Alto, CA, 94304
NPI first listed
2011-04-07
NPI last updated
2024-09-23
NPI record certified
2024-09-23

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 801 Welch Rd, Palo Alto, CA, 94304